The global Overactive Bladder Treatment market was valued at USD 3.44billion in 2016 and is projected to reach USD 4.43billionby 2025, growing at a CAGR of 2.84% from 2017 to 2025.
An overactive bladder causes a sudden urge to urinate. It can also trigger involuntary loss of urine, known as incontinence. Overactive bladder affects mostly women and geriatric population. The health issue is highly prevalent and the market is expected to grow during the forecast period.
The Final Report will cover the impact analysis of COVID-19 on this industry:
Download Sample of This Strategic Report:
1. Market Drivers
1.1 Improved innovations in Intravesical therapies
1.2 High level marketing by pharma companies
1.3 Increase geriatric population
1.4 Rising number of cases of Diseases Characterized By OAB
2. Market Restraints
2.1 Undesired Systemic Effects of Current OAB Treatments
1. By Disease:
1.1 Idiopathic Overactive Bladder
1.2 Neurogenic Overactive Bladder
1.2.1 Overactive Bladder in Parkinson’s Disease
1.2.2 Overactive Bladder in Stroke
1.2.3 Overactive Bladder in Multiple Sclerosis
1.2.4 Overactive Bladder in Spinal Cord Injury
1.2.5 Overactive Bladder in Other Disorders
2. By Pharmacotherapy:
2.1.7 Other Anticholinergics
2.5 Intravesical Instillation
3. By Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa
The major players in the market are as follows:
1. Astellas Pharma Inc.
2. Pfizer, Inc.
3. Teva Pharmaceutical Industries Limited
4. Allergan, PLC.
5. Mylan N.V.
6. Endo International PLC
7. Hisamitsu Pharmaceutical Co., Inc.
9. Aurobindo Pharma Limited
10. Johnson & Johnson
11. Intas Pharmaceuticals Ltd.
12. Apotex Inc.
13. Macleods Pharmaceuticals Ltd.
14. Medtronic PLC
15. Cogentix Medical, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
Request For Full Report: https://www.kennethresearch.com/sample-request-10059482
RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH:
Research study on the Overactive Bladder Treatmentmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the research methodology of verified market research and other aspects of the research study, kindly get in touch with our sales team.
About Kenneth Research:
Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.
Phone: +1 313 462 0609